⌘K
EN
FR
Solution injectable pour examen diagnostique à la TEP - Cancer de la prostate | Government contract · CanPursue
Contracts
active
Solution injectable pour examen diagnostique à la TEP - Cancer de la prostate
CHU de Québec - Université Laval
Novartis Pharma Canada inc.
H25-0332EBO
Watch
Total contract value
$22,400
Original award value
$22,400
Start
May 23, 2025
End
May 23, 2026
Timeline
Official
Awarded
May 23, 2025. Original award value: $22,400
Observed expiry
May 23, 2026